Immuno-oncology drugs, Neurodegenerative disorder treatments
ABL Bio is focused on developing immuno-oncology drugs and neurodegenerative disorder treatments. Their pipeline includes ABL001, an anti-VEGF/DLL4 BsAb for solid cancer, and ABL301, a treatment for Parkinson’s Disease.
Latest News
No feed items found.
| Contact Details | 2nd floor, 16, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-doTEL : 031-8018-9800 |
|---|
GenoFocus is a company that develops special enzymes and microbiome therapeutics. They have developed a range of products including industrial special enzymes such as lactase, catalase, and proteinase K.
LigaChem (LegoChem) Biosciences is a research-focused pharmaceutical company that focuses on medicinal chemistry for global new drug R&D. The company has built a diverse clinical-stage pipeline using its proprietary functional chemical structure (scaffold) with drug-likeness, developed by its research team’s experience and know-how in new drug development.
